Skip to main content
. Author manuscript; available in PMC: 2012 Jul 5.
Published in final edited form as: Circulation. 2011 Jun 20;124(1):17–23. doi: 10.1161/CIRCULATIONAHA.110.003954

Table 5. Cox proportional hazards models of mortality and number of preventative therapies used among PAD subjects without recognized CVD.

Model 1 Model 2 Model 3
N HR (95% CI) p HR (95% CI) p HR (95% CI) p
No preventative therapies* 244 ref ref ref
One preventative therapy 129 1.12 (0.6-2.1) 0.7 1.15 (0.6-2.2) 0.7 1.24 (0.6-2.5) 0.5
Multiple preventative therapies (≥ 2) 77 0.79 (0.4-1.7) 0.5 0.63 (0.2-1.7) 0.3 0.35 (0.2-0.86) 0.02
*

Therapies include statin, anti-platelet therapy, and/or ACEI/ARB.

Model 1 = Adjusted for age, gender, race/ethnicity

Model 2 = Model 1 + atherosclerotic risk factors (diabetes, hypertension, hyperlipidemia, smoking, and chronic kidney disease)

Model 3 = Model 2 + health insurance status, education level, and socioeconomic status (based on poverty-income ratio)